Getinge has announced the expansion of its Servo-c ventilator with the addition of a neonatal option, enabling the device to cater to all patient demographics, including premature newborns and adult patients.
This development aims to support hospitals in delivering personalised respiratory care while managing operational costs.
Getinge critical care vice president Cecilia Sjöstedt said: “Hospitals are under increasing pressure to deliver high-quality care for diverse patient needs while managing costs.
“Servo-c now supports this by enabling personalised respiratory treatment across all patient categories – from premature newborns to full grown adults – with full flexibility in targeted markets. This is part of our commitment to make life-saving technology accessible for more people.”
The neonatal feature allows the ventilator to assist premature infants weighing as little as 500g without additional accessories. The option includes invasive leakage compensation and adheres to international standards for safety, biocompatibility, and cybersecurity.
Servo-c features a 15” intuitive touchscreen and tools such as Servo Compass and Open Lung Tool trends for precise monitoring and recruitment.
The ventilator also includes CO2 monitoring, Stress Index, and High Flow therapy options. With Servo Compass monitoring, clinicians can visualise patients’ breathing within set parameters.
The device’s Open Lung Tools assist with lung recruitment by allowing breath-by-breath adjustments.
For convenience during power outages or patient transfers, Servo-c is said to be equipped with two hot-swappable batteries providing up to three hours of power. These batteries charge when connected to a main power source and indicate remaining time in minutes.
Additionally, the ventilator supports seamless transitions between invasive ventilation, non-invasive ventilation, and High Flow therapy without requiring a device change, aided by built-in tools that can be activated or deactivated as needed.
Sjöstedt said: “Since our first Servo ventilator was introduced over 50 years ago, our focus has been on continuous innovation, better outcomes, increased patient safety and outstanding user experience. We are proud of our legacy and remain committed to leading the way in developing ventilators for the future.”
